Patents by Inventor Qinghua Meng

Qinghua Meng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HETEROCYCLIC GLP-1 AGONISTS
    Publication number: 20240083886
    Abstract: Relates to GLP-1 agonists of Formula (I): including pharmaceutically acceptable salts and solvates thereof, and pharmaceutical compositions including the same.
    Type: Application
    Filed: October 13, 2021
    Publication date: March 14, 2024
    Inventors: Qinghua MENG, Weiqiang XING, Xichen LIN, Andrew JENNINGS
  • Heterocyclic GLP-1 agonists
    Patent number: 11926643
    Abstract: This disclosure relates to GLP-1 agonists of Formula (I): including pharmaceutically acceptable salts and solvates thereof, and pharmaceutical compositions including the same.
    Type: Grant
    Filed: June 29, 2022
    Date of Patent: March 12, 2024
    Assignee: Gasherbrum Bio, Inc.
    Inventors: Qinghua Meng, Xichen Lin, Haizhen Zhang, Weiqiang Xing, Hui Lei, Andrew Jennings
  • Heterocyclic GLP-1 agonists
    Patent number: 11926626
    Abstract: This disclosure relates to GLP-1 agonists of Formula (I), including pharmaceutically acceptable salts and solvates thereof, and pharmaceutical compositions including the same.
    Type: Grant
    Filed: September 21, 2022
    Date of Patent: March 12, 2024
    Assignee: Gasherbrum Bio, Inc.
    Inventors: Qinghua Meng, Weiqiang Xing, Haizhen Zhang, Xichen Lin, Hui Lei, Andrew Jennings
  • Heterocyclic GLP-1 agonists
    Patent number: 11897851
    Abstract: This disclosure relates to GLP-1 agonists of Formula I: including pharmaceutically acceptable salts and solvates thereof, and pharmaceutical compositions including the same.
    Type: Grant
    Filed: February 6, 2023
    Date of Patent: February 13, 2024
    Assignee: Gasherbrum Bio, Inc.
    Inventors: Qinghua Meng, Hui Lei, Haizhen Zhang, Xichen Lin, Andrew Jennings
  • HETEROCYCLIC GLP-1 AGONISTS
    Publication number: 20230391760
    Abstract: This disclosure relates to GLP-1 agonists of Formula (I): including pharmaceutically acceptable salts and solvates thereof, and pharmaceutical compositions including the same.
    Type: Application
    Filed: October 13, 2021
    Publication date: December 7, 2023
    Inventors: Qinghua MENG, Weiqiang XING, Xichen LIN, Andrew JENNINGS
  • HETEROCYCLIC GLP-1 AGONISTS
    Publication number: 20230331732
    Abstract: This disclosure relates to GLP-1 agonists of Formula (I), including pharmaceutically acceptable salts and solvates thereof, and pharmaceutical compositions including the same.
    Type: Application
    Filed: September 8, 2021
    Publication date: October 19, 2023
    Inventors: Qinghua MENG, Weiqiang XING, Haizhen ZHANG, Xichen LIN, Hui LEI, Andrew JENNINGS
  • HETEROCYCLIC GLP-1 AGONISTS
    Publication number: 20230322771
    Abstract: This disclosure relates to GLP-1 agonists of Formula (I), including pharmaceutically acceptable salts and solvates thereof, and pharmaceutical compositions including the same.
    Type: Application
    Filed: September 6, 2021
    Publication date: October 12, 2023
    Inventors: Qinghua MENG, Weiqiang XING, Haizhen ZHANG, Xichen LIN, Hui LEI, Andrew JENNINGS
  • HETEROCYCLIC GLP-1 AGONISTS
    Publication number: 20230295154
    Abstract: This disclosure relates to GLP-1 agonists of Formula (I): including pharmaceutically acceptable salts and solvates thereof, and pharmaceutical compositions including the same.
    Type: Application
    Filed: April 28, 2021
    Publication date: September 21, 2023
    Inventors: Qinghua MENG, Andrew JENNINGS, Hui LEI, Xichen LIN
  • HETEROCYCLIC GLP-1 AGONISTS
    Publication number: 20230192633
    Abstract: This disclosure relates to GLP-1 agonists of Formula I: including pharmaceutically acceptable salts and solvates thereof, and pharmaceutical compositions including the same.
    Type: Application
    Filed: February 6, 2023
    Publication date: June 22, 2023
    Inventors: Qinghua Meng, Hui Lei, Haizhen Zhang, Xichen Lin, Andrew Jennings
  • HETEROCYCLIC GLP-1 AGONISTS
    Publication number: 20230174565
    Abstract: This disclosure relates to GLP-1 agonists of Formula (I): including pharmaceutically acceptable salts and solvates thereof, and pharmaceutical compositions including the same.
    Type: Application
    Filed: June 29, 2022
    Publication date: June 8, 2023
    Inventors: Qinghua MENG, Xichen LIN, Haizhen ZHANG, Weiqiang XING, Hui LEI, Andrew JENNINGS
  • HETEROCYCLIC GLP-1 AGONISTS
    Publication number: 20230165846
    Abstract: Provided are GLP-1 agonists of Formula (I) or (II), including pharmaceutically acceptable salts and solvates thereof, pharmaceutical compositions, and methods of using the same.
    Type: Application
    Filed: February 9, 2021
    Publication date: June 1, 2023
    Inventors: Qinghua MENG, Xichen LIN, Andrew JENNINGS
  • HETEROCYCLIC GLP-1 AGONISTS
    Publication number: 20230107793
    Abstract: This disclosure relates to GLP-1 agonists of Formula (I), including pharmaceutically acceptable salts and solvates thereof, and pharmaceutical compositions including the same.
    Type: Application
    Filed: September 21, 2022
    Publication date: April 6, 2023
    Inventors: Qinghua MENG, Weiqiang XING, Haizhen ZHANG, Xichen LIN, Hui LEI, Andrew JENNINGS
  • HETEROCYCLIC GLP-1 AGONISTS
    Publication number: 20230071840
    Abstract: This disclosure relates to GLP-1 agonists of Formula (I), including pharmaceutically acceptable salts and solvates thereof, and pharmaceutical compositions including the same.
    Type: Application
    Filed: September 22, 2022
    Publication date: March 9, 2023
    Inventors: Qinghua MENG, Weiqiang XING, Haizhen ZHANG, Xichen LIN, Hui LEI, Andrew JENNINGS
  • Heterocyclic GLP-1 agonists
    Patent number: 11492365
    Abstract: This disclosure relates to GLP-1 agonists of Formula (I): including pharmaceutically acceptable salts and solvates thereof, and pharmaceutical compositions including the same.
    Type: Grant
    Filed: January 7, 2022
    Date of Patent: November 8, 2022
    Assignee: GASHERBRUM BIO, INC.
    Inventors: Qinghua Meng, Xichen Lin, Haizhen Zhang, Hui Lei, Andrew Jennings
  • HETEROCYCLIC GLP-1 AGONISTS
    Publication number: 20220213130
    Abstract: This disclosure relates to GLP-1 agonists of Formula (I): including pharmaceutically acceptable salts and solvates thereof, and pharmaceutical compositions including the same.
    Type: Application
    Filed: January 7, 2022
    Publication date: July 7, 2022
    Inventors: Qinghua Meng, Xichen Lin, Haizhen Zhang, Weiqiang Xing, Hui Lei, Andrew Jennings
  • Modulators of the retinoid-related orphan receptor gamma (ROR-gamma) for use in the treatment of autoimmune and inflammatory diseases
    Patent number: 10005731
    Abstract: The present invention relates to novel retinoid-related orphan receptor gamma (ROR?) modulators and their use in the treatment of diseases mediated by ROR?.
    Type: Grant
    Filed: December 5, 2013
    Date of Patent: June 26, 2018
    Assignee: Glaxo Group Limited
    Inventors: Fangbin Han, Hui Lei, Xichen Lin, Qinghua Meng, Yonghui Wang
  • MODULATORS OF THE RETINOID-RELATED ORPHAN RECEPTOR GAMMA (ROR-GAMMA) FOR USE IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES
    Publication number: 20150299121
    Abstract: The present invention relates to novel retinoid-related orphan receptor gamma (ROR?) modulators and their use in the treatment of diseases mediated by ROR?.
    Type: Application
    Filed: December 5, 2013
    Publication date: October 22, 2015
    Applicant: Glaxo Group Limited
    Inventors: Fangbin HAN, Hui LEI, Xichen LIN, Qinghua MENG, Yonghui WANG
  • COMPOUNDS
    Publication number: 20120101123
    Abstract: The present invention relates to novel compounds having pharmacological activity, processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of various disorders.
    Type: Application
    Filed: June 17, 2010
    Publication date: April 26, 2012
    Inventors: Chengyong Li, Xichen Lin, Qinghua Meng, Haibo Zhang
  • 5-MEMBERED HETEROARYL DERIVATIVES USED AS SPHINGOSINE 1-PHOSPHATE RECEPTOR AGONISTS
    Publication number: 20120101134
    Abstract: 5-membered heteroaryl derivatives of formula (I) or salts thereof, processes for their preparation, pharmaceutical compositions containing them and their uses in the treatment of various disorders mediated by S1P1 receptors are disclosed.
    Type: Application
    Filed: June 24, 2010
    Publication date: April 26, 2012
    Applicant: GLAXO GROUP LIMITED
    Inventors: Guanghui Deng, Xichen Lin, Qinghua Meng, Feng Ren, Jia-Ning Xiang, Heng Xu, Haibo Zhang, Baowei Zhao